Paradoxical increase in retinoblastoma protein in colorectal carcinomas may protect cells from apoptosis

Clinical Cancer Research

Volumn 5, Issue 7, 1999, Pages 1805-1815

  Yamamoto, Hirofumi ^a,b   Soh, Jae Won ^a   Monden, Takushi ^b   Klein, Micheal G ^a   Zhang, Li Ming ^a   Shirin, Haim ^a   Arber, Nadir ^c   Tomita, Naohiro ^b   Schieren, Ira ^a   Stein, C A ^a   Weinstein, I Bernard ^a  

^a New York Presbyterian Columbia University Medical Center   (United States)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CYCLIN D1; PROTEIN KINASE; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F;

APOPTOSIS; ARTICLE; CANCER GROWTH; COLON CARCINOGENESIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

APOPTOSIS; CARRIER PROTEINS; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIVISION; CELL SIZE; CELLS, CULTURED; COLORECTAL NEOPLASMS; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; HUMANS; IMMUNOHISTOCHEMISTRY; OLIGONUCLEOTIDES, ANTISENSE; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0032791417     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Friend, S. H., Bernards, R., Rogelj, S., Weinberg, R. A., Rapaport, J. M., Albert, D. M., and Dryja, T. P. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature (Lond.). 323: 643-646, 1986.
2. Lee, W. H., Bookstein, R., Hong, F., Young, L. J., Shew, J. Y., and Lee, E. Y. Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science, 235: 1394-1399, 1987.
3. Fung, Y. K., Murphree, A. L., T'Ang, A., Qian, J., Hinrichs, S. H., and Benedict, W. F. Structural evidence for the authenticity of the human retinoblastoma gene. Science (Washington DC), 236: 1657-1661, 1987.
4. Wildrick, D. M., and Boman, B. M. Does the human retinoblastoma gene have a role in colon cancer? Mol. Carcinog., 10: 1-7, 1994.
5. Gope, R., Christensen, M. A., Thorson, A., Lynch, H. T., Smyrk, T., Hodgson, C., Wildrick, D. M., Gope, M. L., and Boman, B. M. Increased expression of the retinoblastoma gene in human colorectal carcinomas relative to normal colonic mucosa. J. Natl. Cancer Inst., 82: 310-314, 1990.
6. Gope, R., and Gope, M. L. Abundance and state of phosphorylation of the retinoblastoma susceptibility gene product in human colon cancer. Mol. Cell. Biochem., 110: 123-133, 1992.
7. Yamamoto, H., Monden, T., Ikeda, K., Izawa, H., Fukuda, K., Fukunaga, M., Tomita, N., Shimano, T., Shiozaki, H., and Monden, M. Coexpression of cdk2/cdc2 and retinoblastoma gene products in colorectal cancer. Br. J. Cancer, 71: 1231-1236, 1995.
8. Poller, D. N., Baxter, K. J., and Shepherd, N. A. p53 and Rb1 protein expression: are they prognostically useful in colorectal cancer? Br. J. Cancer, 75: 87-93, 1997.
9. Hunter, T., and Pines, J. Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell, 79: 573-582, 1994.
10. Arber, N., Hibshoosh, H., Moss, S. F., Sutter, T., Zhang, Y., Begg, M., Wang, S., Weinstein, I. B., and Holt, P. R. Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. Gastroenterology, 110: 669-674, 1996.
11. Yasui, W., Kuniyasu, H., Yokozaki, H., Semba, S., Shimamoto, F., and Tahara, E. Expression of cyclin E in colorectal adenomas and adenocarcinomas: correlation with expression of Ki-67 antigen and p53 protein. Virchows Arch., 429: 13-19, 1996.
12. Kitahara, K., Yasui, W., Kuniyasu, H., Yokozaki, H., Akama, Y., Yunotani, S., Hisatsugu, T., and Tahara, E. Concurrent amplification of cyclin E and CDK2 genes in colorectal carcinomas. Int. J. Cancer, 62: 25-28, 1995.
13. Leach, F. S., Elledge, S. J., Sherr, C. J., Willson, J. K., Markowitz, S., Kinzler, K. W., and Vogelstein, B. Amplification of cyclin genes in colorectal carcinomas. Cancer Res., 53: 1986-1989, 1993.
14. Herman, J. G., Merlo, A., Mao, L., Lapidus, R. G., Issa, J. P., Davidson, N. E., Sidransky, D., and Baylin, S. B. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res., 55: 4523-4530, 1995.
15. Matsushita, K., Kobayashi, S., Kato, M., Itoh, Y., Okuyama, K., Sakiyama, S., and Isono, K. Reduced messenger RNA expression level of p21 CIP1 in human colorectal carcinoma tissues and its association with p53 gene mutation. Int. J. Cancer, 69: 259-264, 1996.
16. Polyak, K., Hamilton, S. R., Vogelstein, B., and Kintzler, K. W. Early alterations of cell-cycle-regulated gene expression in colorectal neoplasia. Am. J. Pathol., 149: 381-387, 1996.
17. Ciaparrone, M., Yamamoto, H., Yao, Y., Sgambato, A., Cattoretti, G., Tomita, N., Monden, T., Rotterdam, H., and Weinstein, I. B. Localization and expression of p27Kip1 in multistage colorectal carcinogenesis. Cancer Res., 58: 114-122, 1998.
18. Loda, M., Cukor, B., Tam, S. W., Lavin, P., Fiorentino, M., Draetta, G. F., Jessup, J. M., and Pagano, M. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat. Med., 3: 231-234, 1997.
19. Algar, E. M., Khromykh, T., Smith, S. I., Blackburn, D. M., Bryson, G. J., and Smith, P. J. A WT1 antisense oligonucleotide inhibits proliferation and induces apoptosis in myeloid leukaemia cell lines. Oncogene, 12: 1005-1014, 1996.
20. Fan, G., Ma, X., Kren, B. T., and Steer, C. J. The retinoblastoma gene product inhibits TGF-β1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells. Oncogene, 12: 1909-1919, 1996.
21. Strauss, M., Hering, S., Lieber, A., Herrmann, G., Griffin, B. E., and Arnold, W. Stimulation of cell division and fibroblast focus formation by antisense repression of retinoblastoma protein synthesis. Oncogene, 7: 769-773, 1992.
22. Koike, M., Ishino, K., Ikuta, T., Huh, N., an Kuroki, T. Growth enhancement of normal human keratinocytes by the antisense oligonucleotide of retinoblastoma susceptibility gene. Oncogene, 10: 117-122, 1995.
23. Yamamoto, H., Soh, J. W., Shirin, H., Xing, W. Q., Lim, J. T., Yao, Y., Slosberg, E., Tomita, N., Schieren, I., and Weinstein, I. B. Comparative effects of overexpression of p27Kip1 and p21Cip1/Waf1 on growth and differentiation in human colon carcinoma cells. Oncogene, 18: 103-115, 1999.
24. Wong, K. K., Zou, X., Merrell, K. T., Patel, A. J., Marcu, K. B., Chellappan, S., and Calame, K. v-Ab1 activates c-myc transcription through the E2F site. Mol. Cell. Biol., 15: 6535-6544, 1995.
25. Riggs, K. J., Saleque, S., Wong, K. K., Merrell, K. T., Lee, J. S., Shi, Y., and Calame, K. Yin-yang 1 activates the c-myc promoter. Mol. Cell. Biol., 13: 7487-7495, 1993.
26. Shan, B., Zhu, X., Chen, P. L., Durfee, T., Yang, Y., Sharp, D., and Lee, W. H. Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: identification of a gene with properties of the transcription factor E2F. Mol. Cell. Biol., 12: 5620-5631, 1992.
27. Hunt, K. K., Deng, J., Liu, T. J., Wilson-Heiner, M., Swisher, S. G., Clayman, G., and Hung, M. C. Adenovirus-mediated overexpression of the transcription factor E2F-1 induces apoptosis in human breast and ovarian carcinoma cell lines and does not require p53. Cancer Res., 57: 4722-4726, 1997.
28. Ali, A. A., Marcus, J. N., Harvey, J. P., Roll, R., Hodgson, C. P., Wildrick, D. M., Chakraborty, A., and Bomam, B. M. RB1 protein in normal and malignant human colorectal tissue and colon cancer cell lines. FASEB J., 7: 931-937, 1993.
29. Moss, S. F., Scholes, J. V., and Holt, P. R. Abnormalities of epithelial apoptosis in multistep colorectal neoplasia demonstrated by terminal deoxyuridine nick end labeling. Dig. Dis. Sci., 41: 2238-2247, 1996.
30. Doglioni, C., Pelosio, P., Laurino, L., Marci, E., Meggiolaro, E., Favretti, F., and Barbareschi, M. p21/WAF1/CIP1 expression in normal mucosa and in adenomatous and adenocarcinomas of the colon: its relationship with differentiation. J. Pathol., 179: 248-253, 1996.
31. Wakasugi, E., Kobayashi, T., Tamaki, Y., Nakano, Y., Ito, Y., Miyashiro, I., Komoike, Y., Miyazaki, M., Takeda, T., Monden, T., and Monden, M. Analysis of phosphorylation of pRB and its regulatory proteins in breast cancer. J. Clin. Pathol., 50: 407-412, 1997.
32. 1 phase of the cell cycle. Cell, 67: 293-302, 1991.
33. Stein, C. A. Does antisense exist? Nat. Med., 1: 1119-1121, 1995.
34. Stein, C. A., and Krieg, A. Problems in interpretation of data derived from in vitro and in vivo use of antisense oligodeoxynucleotides. Antisense Res. Dev., 4: 67-69, 1994.
35. Stein, C. A. How to design an antisense oligodeoxynucleotide experiment: a consensus approach. Antisense Nucleic Acid Drug Dev., 8: 129-132, 1998.
36. Dean, N. M., and McKay, R. Inhibition of protein kinase C-α expression in mice after systemic administration of phosphorothioate antisense oligodeoxynucleotides. Proc. Natl. Acad. Sci. USA, 91: 11762-11766, 1994.
37. Monia, B. P., Johnston, J. F., Geiger, T., Muller, M., and Fabbro, D. Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase. Nat. Med., 2: 668-675, 1996.
38. Valente, P., Melchiori, A., Paggi, M. G., Masiello, L., Ribatti, D., Santi, L., Takahashi, R., Albini, A., and Noonan, D. M. RB1 oncosuppressor gene overexpression inhibits tumor progression and induces melanogenesis in metastatic melanoma cells. Oncogene, 13: 1169-1178, 1996.
39. 1 phase arrest induced by Wilms tumor protein WT1 is abrogated by cyclin/CDK complexes. Proc. Natl. Acad. Sci., USA, 92: 4517-4521, 1995.
40. Yamagami, T., Sugiyama, H., Inoue, K., Ogawa, H., Tatekawa, T., Hirata, M., Kudou, T., Akiyama, T., Murakami, A., and Maekawa, T. Growth inhibition of human leukemic cells by WT1 antisense oligodeoxynucleotides: implications for the involvement of WT1 in leukemogenesis. Blood, 87: 2878-2884, 1996.
41. Muller, H., Lukas, J., Schneider, A., Warthoe, P., Bartek, J., Eilers, M., and Strauss, M. Cyclin D1 expression is regulated by the retinoblastoma protein. Proc. Natl. Acad. Sci. USA, 91: 2945-2949, 1994.
42. Doki, Y., Imoto, M., Han, E. K., Sgambato, A., and Weinstein, I. B. Increased expression of the p27KIP1 protein in human esophageal cancer cell lines that overexpress cyclin D1. Carcinogenesis (Lond.), 18: 1139-1148, 1997.
43. Arber, N., Doki, Y., Han, E. K., Sgambato, A., Zhou, P., Kim, N. H., Delohery, T., Klein, M. G., Holt, P. R., and Weinstein, I. B. Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells. Cancer Res., 57: 1569-1574, 1997.
44. Hiyama, H., Iavarone, A., LaBaer, J., and Reeves, S. A. Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell cycle progression. Oncogene, 14: 2533-2542, 1997.
45. Zhang, T., Nanney, L. B., Luongo, C., Lamps, L., Heppner, K. J., DuBois, R. N., and Beauchamp, R. D. Concurrent overexpression of cyclin D1 and cyclin-dependant kinase 4 (Cdk4) in intestinal adenomas from multiple intestinal neoplasia mice and human familial adenomatous polyposis patients. Cancer Res., 57: 169-175, 1997.
46. McConkey, D. J., Goodrich, D., Bucana, C., and Klostergaard, J. The human retinoblastoma gene product suppresses ceramide-induced apoptosis in human bladder tumor cells. Oncogene, 13: 1693-1700, 1996.
47. Berry, D. E., Lu, Y., Schmidt, B., Fallon, P. G., O'Connell, C., Hu, S. X., Xu, H. J., and Blanck, G. Retinoblastoma protein inhibits IFN-γ induced apoptosis. Oncogene, 12: 1809-1819, 1996.
48. Haas-Kogan, D. A., Kogan, S. C., Levi, D., Dazin, P., T'Ang, A., Fung, Y. K., and Israel, M. A. Inhibition of apoptosis by the retinoblastoma gene product. EMBO J., 14: 461-472, 1995.
49. Zwicker, J., Liu, N., England, K., Lucibello, F. C., and Muller, R. Cell cycle regulation of E2F site occupation in vivo. Science (Washington DC), 271: 1595-1597, 1996.
50. Field, S. J., Tsai, F. Y., Kuo, F., Zubiaga, A. M., Kaelin, W. G., Jr., Livingston, D. M., Orkin, S. H., and Greenberg, M. E. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell, 85: 549-561, 1996.
51. Shan, B. and Lee, W. H. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol. Cell. Biol., 14: 8166-8173, 1994.
52. Cuevo, R. S., Garrett, S., and Horowitz, J. M. Detection and functional characterization of p180, a novel cell cycle regulated yeast transcription factor that binds retinoblastoma control elements. J. Biol. Chem., 272: 3813-3822, 1997.
53. Chen, P. L., Riley, D. J., Chen-Kiang, S., and Lee, W. H. Retinoblastoma protein directly interacts with and activates the transcription factor NF-IL6. Proc. Natl. Acad. Sci. USA, 93: 465-469, 1996.
54. Take, Y., Kumano, M., Teraoka, H., Nishimura, S., and Okuyama, A. DNA-dependent protein kinase inhibitor (OK-1035) suppresses p21 expression in HCT116 cells containing wild-type p53 induced by adriamycin. Biochem. Biophys. Res. Commun., 221: 207-212, 1996.
55. Rodrigues, N. R., Rowan, A., Smith, M. E., Kerr, I. B., Bodmer, W. F., Gannon, J. V., and Lane, D. P. p53 mutations in colorectal cancer. Proc. Natl. Acad. Sci. USA, 87: 7555-7559, 1990.
56. Lemass, H., Ryan, E., Mathuna, P. M., Crowe, J., and O'Keane, J. C. Elevated pRB is associated with elevated E2F-1 but not cyclin D1 or cyclin-dependent kinase 4 in the colorectal carcinoma cell cycle. Gastroenterology, 114: G2612, 1998.
57. Esposito, V., Baldi, A., De Luca, A., Groger, A. M., Loda, M., Giordano, G. G., Caputi, M., Baldi, F., Pagano, M., and Giordano, A. Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Res., 57: 3381-3385, 1997.
58. Sgambato, A., Zhang, Y. J., Arber, N., Hibshoosh, H., Doki, Y., Ciaparrone, M., Santella, R. M., Weinstein, I. B. Deregulated expression of p27Kip1 in human breast cancers. Clin. Cancer Res., 3: 1879-1887, 1997.
59. Catzavelos, C., Bhattacharya, N., Ung, Y. C., Wilson, J. A., Roncari, L., Sandhu, C., Shaw, P., Yeger, H., Morava-Protzner, I., Kapusta, L., Franssen, E., Pritchard, K. I., and Slingerland, J. M. Decreased level of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer. Nat. Med., 3: 227-230, 1997.
60. Barbareschi, M., Caffo, O., Doglioni, C., Fina, P., Marchetti, A., Buttitta, F., Leek, R., Morelli, L., Leonardi, E., Bevilacqua, G., Dalla Palma, P., and Harris, A. L. p21WAF1 immunohistochemical expression in breast carcinoma: correlations with clinicopathological data, oestrogen receptor status, MIB1 expression, p53 gene and protein alterations and relapse-free survival. Br. J. Cancer, 74: 208-215, 1996.
61. Jung, J. M., Bruner, J. M., Ruan, S., Langford, L. A., Kyritsis, A. P., Kobayashi, T., Levin, V. A., and Zhang, W. Increased levels of p21WAF1/Cip1 in human brain tumors. Oncogene, 11: 2021-2028, 1995.
62. Marchetti, A., Doglioni, C., Barbareschi, M., Buttitta, F., Pellegrini, S., Bertacca, G., Chella, A., Merlo, G., Angeletti, C. A., Dalla Palma, P., and Bevilacqua, G. p21 RNA and protein expression in non-small cell lung carcinomas: evidence of p53-independent expression and association with tumoral differentiation. Oncogene, 12: 1319-1324, 1996.
63. Kornblau, S. M., Xu, H. J., Zhang, W., Hu, S. X., Beran, M., Smith, T. L., Hester, J., Estey, E., Benedict, W. F., and Deisseroth, A. B. Levels of retinoblastoma protein expression in newly diagnosed acute myelogenous leukemia. Blood, 84: 256-261, 1994.
64. Cote, R. J., Dunn, M. D., Chatterjee, S. J., Stein, J. P., Shi, S. R., Tran, Q. C., Hu, S. X., Xu, H. J., Groshen, S., Taylor, C. R., Skinner, D. G., and Benedict, W. F. Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53. Cancer Res., 58: 1090-1094, 1998.
65. Trudel, M., Mulligan, L., Cavenee, W., Margolese, R., Cote, J., and Gariepy, G. Retinoblastoma and p53 gene product expression in breast carcinoma: immunohistochemical analysis and clinicopathologic correlation. Hum. Pathol., 23: 1388-1394, 1992.
66. Grossman, H. B., Liebert, M., Antelo, M., Dinney, C. P., Hu, S. X., Palmer, J. L., Benedict, W. F. p53 and RB expression predict progression in T1 bladder cancer. Clin. Cancer Res., 4: 829-834, 1998.
67. Otterson, G. A., Kratzke, R. A., Coxon, A., Kim, Y. W., and Kaye, F. J. Absence of p16INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB. Oncogene, 9: 3375-3378, 1994.